Comorbidities and diabetic complications in patients with necrobiosis lipoidica

J Am Acad Dermatol. 2022 Apr;86(4):891-894. doi: 10.1016/j.jaad.2021.03.026. Epub 2021 Mar 17.

Authors

Kevin J Severson¹, Meera H Patel¹, Caitlin M Brumfiel¹, Ilana Breen², Richard J Butterfield³, Steven A Nelson¹, Aleksander Sekulic¹, Mark R Pittelkow¹, Aaron R Mangold⁴

Affiliations

¹ Department of Dermatology, Mayo Clinic Arizona, Scottsdale, Arizona.
² Mayo Clinic Alix School of Medicine, Scottsdale, Arizona.
³ Department of Biostatistics, Mayo Clinic Arizona, Scottsdale, Arizona.
⁴ Department of Dermatology, Mayo Clinic Arizona, Scottsdale, Arizona. Electronic address: mangold.aaron@mayo.edu.

PMID: 33722550
DOI: 10.1016/j.jaad.2021.03.026

No abstract available

Publication types

Letter

MeSH terms

Comorbidity
Diabetes Complications* / epidemiology
Diabetes Mellitus, Type 1* / complications
Humans
Necrobiosis Lipoidica* / complications
Necrobiosis Lipoidica* / epidemiology